ERDERA Clinical Trial Call – Call Text

1:1
Call text draft setting out rules, eligibility and staged application process for the ERDERA Clinical Trial Call 2026.

Call text draft for the ERDERA Clinical Trial Call, describing governance, scope (in scope/out of scope), funding mechanism, eligibility criteria, application stages (including Stage 0 Expression of Interest and Stage 1 Short Proposal), evaluation, and annexed definitions and indicative timeline. It includes submission deadlines for Expressions of Interest (10 September 2026) and Short Proposals (29 October 2026) and provides a contact email for the Scientific Secretariat.

Version 3.1 | 24th July 2026

This call text may be subject to minor revisions. Applicants are responsible for regularly verifying that they are consulting the latest available version.

Acces this publication

publication

ERDERA clinical trial call

Year of publication

2026

Source

European Rare Diseases Research Alliance (ERDERA)

Author

You might also be interested in

ERDERA - GAM day 2 - JVDPhotography-65

ERDERA announces its 2026 Open Session

This free online session will highlight patient and research perspectives, innovative clinical study methods, and emerging regulatory approaches
ERDERA trainings template (7)

Regulatory Insights of Advanced Therapies Research & Development

September 30 @ 1:00 pm - 2:00 pm
This ERDERA webinar will provide an overview of the regulatory and ethical requirements for advanced therapy medicinal product (ATMP) research, with a particular focus on genome editing and paediatric studies in rare diseases.
October 2026 (5)

ERDERA’s Open Session – 3rd General Assembly Meeting

October 21 @ 2:30 pm - 5:30 pm
A special anniversary event showcasing how innovation, collaboration and novel trial methodologies are advancing rare disease research.
ERDERA trainings template (9)

The 2027 Open Academy x ERDERA Schools is now open for application

Applications for the 2027 Open Academy x ERDERA Schools offer patient advocates and early-career researchers the opportunity to strengthen their knowledge and participation in rare disease research.

ERDERA's

search form